Clinical trial · Interventional
2D-radiotherapy in Palliation of Advanced Esophageal Cancer
Short-course Accelerated 2D-radiotherapy in Palliative Treatment of Advanced Esophageal Cancer
NCT03922152CI-TRIAL-00040616SHARON-2DcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study wants to define the efficacy of a short course 2D-radiation therapy in patients with symptomatic advanced esophageal cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Palliative Care | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Short course radiotherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Short course radiotherapy
- description
- The radiotherapy is delivered over 2 days with accelerated hypo-fractionation and 2D-technique.
- interventionNames
- Radiation: Short course radiotherapy
Primary outcomes (1)
- measure
- Assessment of symptoms [odynophagia, chest-back pain, dysphagia, regurgitation]
- timeFrame
- 1 year
- description
- Symptoms were graded using the IAEA scoring system. Values range from 0 (no symptom) to 4 (severe symptom).
Secondary outcomes (3)
- measure
- Incidence of Treatment-Emergent Adverse Events [Acute radiation toxicity]
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * histologically proven advanced esophageal cancer * excluded from curative therapy because of disease stage and/or presence of multiple comorbidities and/or poor performance status * age \> 18 years * Eastern Cooperative Oncology Group (ECOG) \<3 Exclusion Criteria: * prior radiotherapy to the same region
References
Publications (0)
Data not yet available
No reference posted for this study.